Evolus EOLS
NASDAQ EOLS
$8.37 -0.23 (-2.67%)
As of: Aug 20, 2026 · 3:53 PM EDT

Evolus (EOLS) Return on Assets (2018 - 2026)

Evolus' (EOLS) quarterly Return on Assets came in at 0.0% in Q1 2026, little changed YoY from 0.0% in Q1 2025, and up 16.22% on a QoQ basis from 0.0% in Q4 2025.

Evolus (EOLS) Return on Assets (2018 - 2026) Analysis & Trends

Evolus (EOLS) has 9 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.

  • Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Assets grew to 0.0% in Q1 2026, from 0.0% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2026 to a low of 0.0% in Q1 2023.
  • A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Assets.
  • The widest YoY moves for Return on Assets: up 0 bps in 2022, down 0 bps in 2022.
  • Tracing EOLS's Return on Assets over 5 years: stood at 0.0% in 2022, then advanced by 14 bps to 0.0% in 2023, then surged by 37 bps to 0.0% in 2024, then slipped by 6 bps to 0.0% in 2025, then advanced by 16 bps to 0.0% in 2026.
  • The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Haleon 43.85 Bn 42.88 Bn - 0.00%
2 Teva Pharmaceutical Industries 43.02 Bn 39.37 Bn 2.15 Bn 0.00%
3 Zoetis 31.47 Bn 29.79 Bn 1.05 Bn 0.00%
4 Takeda Pharmaceutical 28.59 Bn 22.79 Bn 5.10 Bn 0.00%
5 United Therapeutics 22.20 Bn 19.53 Bn 683.80 Mn 0.00%
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 0.00%
7 Neurocrine Biosciences 15.45 Bn 15.06 Bn 935.80 Mn 0.00%
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn 0.00%
9 Dr Reddys Laboratories 10.10 Bn 9.94 Bn - 0.00%
10 Evolus 549.85 Mn 504.68 Mn 57.18 Mn 0.00%

Historic Data

Download Data
DateValue
Jun 30, 2026 0.00%
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 -0.01%